HOT

HOTAcclaimed Novelist Sophie Kinsella Announces Brain Cancer Diagnosis READ NOW
HOT2023 Makeup Trends READ NOW
HOTDesperate Search for Missing Migrant Boat Canary Islands READ NOW
HOTTasha Ghouri Looks Red Hot as She Soaks Up The Sun in Stunning Silver Bikini READ NOW
HOTLady Gaga Unknown Photos READ NOW
HOTAmanda Holden Sails Away in New Swimwear Collection READ NOW
HOTMajor Automakers Unite for North American EV Charging Network Expansion READ NOW
HOTLos Angeles Angels Make Franchise History with Record-Breaking 25-1 Victory over Rockies READ NOW
HOTThe Benefits of Practicing Yoga READ NOW
HOTGoogle Maps Redesign Enhances Direction Search READ NOW
HOMEPAGE
parafiks menu
ADVERTISE :)
GET NEWS FROM THE WORLD OR LOCALLY! PLICKER OFFERS YOU A GREAT CONTENT EXPERIENCE AND GUIDANCE. START NOW TO EXPERIENCE. STAY HAPPY.
Sam Bennett

Sam Bennett

6 Jun 2023

2 DK READ

41 Read.

Breakthrough Ovarian Cancer Test Shows Potential for Early Detection

A breakthrough ovarian cancer test has emerged that may revolutionize the early detection of ovarian cancer. A disease known for its late diagnosis and high fatality rates.

Epithelial ovarian cancer, which accounts for 90% of ovarian cancer cases. Often goes unnoticed until advanced stages, making treatment challenging and outcomes poor.

The current diagnostic tool for ovarian cancer relies on a blood test measuring the protein CA125. However, this method is not always reliable in detecting the disease.

As evident from a recent population screening program in the UK that failed to significantly reduce ovarian cancer-related deaths.

In an effort to develop a more effective test, a team led by Pan Wang from Peking University in China conducted a study involving 219 women with various types and stages of cancer.

They collected uterine fluid, which contains cells and metabolic products associated with the ovaries and fallopian tubes. And analyzed it using mass spectrometers.

New Ovarian Cancer Test Offers Hope for Early Detection

Ovarian Cancer Test

The researchers focused on 96 women to identify distinct metabolites present in the uterine fluid of those with early-stage ovarian cancer.

They discovered a group of seven metabolites, including amino acids like tyrosine and phenylalanine. That exhibited significant differences in levels, making them potential markers for diagnosis.

Subsequently, the team tested the uterine fluid from the remaining 123 women. Assessing the presence of these seven metabolites along with the CA125 test.

The new test proved highly accurate in identifying early-stage ovarian cancer cases, outperforming the CA125 test and offering the potential for earlier detection.

While the results are promising, further validation in a larger sample is necessary, according to Eric Eisenhauer from Massachusetts General Hospital in Boston.

He highlights the challenge of non-surgical ovarian cancer test for early-stage ovarian cancer and the difficulties encountered in current detection methods.

Eisenhauer expresses enthusiasm for the findings, describing them as promising and holding great potential.

Breakthrough Ovarian Cancer Test Shows Potential for Early Detection